Morgan Stanley’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.04M | Sell |
|
|||||
|
2025
Q1 | $9.48M | Buy |
|
|||||
|
2024
Q4 | $13.9M | Buy |
|
|||||
|
2024
Q3 | $4.37M | Sell |
|
|||||
|
2024
Q2 | $7.39M | Buy |
|
|||||
|
2024
Q1 | $4.4M | Sell |
|
|||||
|
2023
Q4 | $6.61M | Buy |
|
|||||
|
2023
Q3 | $2.06M | Buy |
|
|||||
|
2023
Q2 | $1.34M | Sell |
|
|||||
|
2023
Q1 | $2.26M | Sell |
|
|||||
|
2022
Q4 | $11.1M | Buy |
|
|||||
|
2022
Q3 | $6.77M | Buy |
|
|||||
|
2022
Q2 | $5.05M | Buy |
|
|||||
|
2022
Q1 | $1.72M | Sell |
|
|||||
|
2021
Q4 | $2.23M | Sell |
|
|||||
|
2021
Q3 | $5.44M | Buy |
|
|||||
|
2021
Q2 | $8.18M | Buy |
|
|||||
|
2021
Q1 | $3.02M | Sell |
|
|||||
|
2020
Q4 | $6.12M | Buy |
|
|||||
|
2020
Q3 | $1.29M | Sell |
|
|||||
|
2020
Q2 | $2.55M | Buy |
|
|||||
|
2020
Q1 | $627K | Sell |
|
|||||
|
2019
Q4 | $3.52M | Buy |
|
|||||
|
2019
Q3 | $761K | Sell |
|
|||||
|
2019
Q2 | $4.03M | Buy |
|
|||||
|
2019
Q1 | $2.29M | Sell |
|
|||||
|
2018
Q4 | $9.06M | Buy |
|
|||||
|
2018
Q3 | $3.18M | Sell |
|
|||||
|
2018
Q2 | $3.1M | Buy |
|
|||||
|
2018
Q1 | $5.01M | Sell |
|
|||||
|
2017
Q4 | $5.38M | Buy |
|
|||||
|
2017
Q3 | $1.66M | Sell |
|
|||||
|
2017
Q2 | $2.05M | Sell |
|
|||||
|
2017
Q1 | $2.74M | Sell |
|
|||||
|
2016
Q4 | $1M | Buy |
|
|||||
|
2016
Q3 | $680K | Sell |
|
|||||
|
2016
Q2 | $1.25M | Buy |
|
|||||
|
2016
Q1 | $452K | Sell |
|
|||||
|
2015
Q4 | $704K | Sell |
|
|||||
|
2015
Q3 | $837K | Sell |
|
|||||
|
2015
Q2 | $6.53M | Buy |
|
|||||
|
2015
Q1 | $4.81M | Sell |
|
|||||
|
2014
Q4 | $4.04M | Sell |
|
|||||
|
2014
Q3 | $3.5M | Sell |
|
|||||
|
2014
Q2 | $2.49M | Sell |
|
|||||
|
2014
Q1 | $2.53M | Buy |
|
|||||
|
2013
Q4 | $593K | Sell |
|
|||||
|
2013
Q3 | $3.63M | Buy |
|